Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer
Malipo:T/T, L/C
Asili ya Bidhaa:China
Bandari ya Usafirishaji:Beijing/Shanghai/Hangzhou
Uwezo wa uzalishaji:100kg/mwezi
Agizo (MOQ):25kg
Muda wa Kuongoza:Siku 3 za Kazi
Hali ya uhifadhi:Imehifadhiwa mahali baridi, kavu, joto la kawaida.
Nyenzo za kifurushi:ngoma
Ukubwa wa kifurushi:25kg/ngoma
Taarifa za usalama:Si bidhaa hatari
Utangulizi
Tofacitinib, ni dawa inayotumika kutibu arthritis ya rheumatoid, psoriatic arthritis, na colitis ya ulcerative.
Tofacitinib citrate hutumika kutibu watu wazima walio na ugonjwa wa baridi yabisi wa wastani hadi ukali ambao wamekuwa na mwitikio duni wa methotrexate, au ambao hawawezi kuvumilia.
Tofacitinib citrate inaonyeshwa kwa ajili ya matibabu ya baridi yabisi yabisi ya baridi yabisi (RA) kwa watu wazima ambao wameitikia ipasavyo, au ambao hawawezi kuvumilia dawa moja au zaidi za kurekebisha ugonjwa.
Uainishaji (nyumbani)
| Kipengee | Vipimo |
| Mwonekano | Poda ya fuwele nyeupe au nyeupe |
| Utambulisho | IR, HPLC |
| Maji | ≤1.5% |
| Dutu Zinazohusiana | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib isiyo na haidrojeni ≤0.15% | |
| Kila uchafu usiojulikana ≤0.10% | |
| Jumla ya Uchafu: ≤1.0% | |
| Vimumunyisho vya Mabaki | Ethanoli ≤5000ppm |
| Benzene ≤2ppm | |
| Toluini ≤890ppm | |
| Chlroroethane ≤1000ppm | |
| N,N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| Majivu yenye sulphate | ≤0.1% |
| Metali Nzito | ≤10ppm |
| Chrial HPLC | 3S, 4S tofacitinib ≤0.15% |
| Upimaji (kwa msingi usio na maji) 98.0-102.0% |
